LXRX
Lexicon Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$852.86M
P/E Ratio
—
EPS
$-0.07
Beta
1.07
52W High
$2.53
52W Low
$0.64
50-Day MA
$1.90
200-Day MA
$1.51
Dividend Yield
—
Profit Margin
-37.50%
Forward P/E
—
PEG Ratio
-0.14
About Lexicon Pharmaceuticals Inc
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of pharmaceutical products. The company is headquartered in The Woodlands, Texas.
Fundamentals
| Revenue (TTM) | $69.64M |
| Gross Profit (TTM) | $65.55M |
| EBITDA | $-23.67M |
| Operating Margin | -4.72% |
| Return on Equity | -16.00% |
| Return on Assets | -5.35% |
| Revenue/Share (TTM) | $0.19 |
| Book Value | $0.48 |
| Price-to-Book | 4.20 |
| Price-to-Sales (TTM) | 12.25 |
| EV/Revenue | 10.62 |
| EV/EBITDA | 16.57 |
| Quarterly Earnings Growth (YoY) | -63.40% |
| Quarterly Revenue Growth (YoY) | 1572.00% |
| Shares Outstanding | $444.20M |
| Float | $262.53M |
| % Insiders | 1.12% |
| % Institutions | 78.73% |
Historical Volatility
HV 10-Day
55.67%
HV 20-Day
54.48%
HV 30-Day
85.05%
HV 60-Day
74.00%
HV Rank
55.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($3.77 target)
1
Strong Buy2
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026